M C28 (Clopidogrel bisulfate 300 mg (base))
Pill imprint M C28 has been identified as Clopidogrel bisulfate 300 mg (base).
Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; heart attack; transient ischemic attack; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M C28
- Strength:
- 300 mg (base)
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00378-3628
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
More about clopidogrel
Consumer resources
- Other brands: Plavix
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
